Long-Term Follow-Up of Patients With Hairy Cell Leukemia After Cladribine Treatment

Alan Saven, Carol Burian, James A. Koziol, +1

Blood

Extended Follow-Up of Patients With Hairy Cell Leukemia After Treatment With Cladribine

Grant R. Goodman, Carol Burian, James A. Koziol, +1

Journal of Clinical Oncology

Cladribine Activity in Adult Langerhans-Cell Histiocytosis

Alan Saven, Carol Burian

Blood

Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series

Joshua D. Rosenberg, Carol Burian, Jill Waalen, +1

Blood

Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine

Darren Sigal, Robert W. Sharpe, Carol Burian, +1

Blood

Bolus administration of cladribine in the treatment of Waldenström macroglobulinaemia

Eva S. Liu, Carol Burian, William E. Miller, +1

British Journal of Haematology

Filgrastim for Cladribine-Induced Neutropenic Fever in Patients With Hairy Cell Leukemia

Alan Saven, Carol Burian, Jasvant Adusumalli, +1

Blood

The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors

Ali Khateb, Anagha Deshpande, Yongmei Feng, +22

Nature Communications

Cladribine Activity in Adult Langerhans-Cell Histiocytosis

Alan Saven, Carol Burian

Blood

Long-Term Follow-Up of Patients With Hairy Cell Leukemia After Cladribine Treatment

Alan Saven, Carol Burian, James A. Koziol, +1

Blood